Vistagen Therapeutics, Inc. Earnings Per Share Diluted

• Vistagen Therapeutics, Inc. showed a decrease of -9.9% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from Vistagen Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on June 17, 2025.
• XBRL data for this metric is available from 2011 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2011 to 2025), Vistagen Therapeutics, Inc.'s Earnings Per Share Diluted has grown by 7.7%.
• Historical annual values: Fiscal year 2025: $1.67 (loss) per share | Fiscal year 2024: $1.52 (loss) per share | Fiscal year 2023: $8.51 (loss) per share | Fiscal year 2016: $29.08 (loss) per share | Fiscal year 2015: $10.61 (loss) per share | Fiscal year 2014: $3.81 (loss) per share | Fiscal year 2013: $1.27 (loss) per share | Fiscal year 2012: $0.83 (loss) per share | Fiscal year 2011: $1.81 (loss) per share.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026